Minh-Ha T. Do

Minh-Ha T. Do currently serves as Vice President of Research at Rampart Bioscience, where responsibilities include overseeing non-clinical in vivo pharmacology and toxicology for cell and gene therapy programs. Previously, at Lumos Pharma, Minh-Ha held the position of Director of Pre-Clinical Innovation, managing various non-clinical development aspects for rare disease programs and authoring regulatory documents. Minh-Ha's earlier tenure at aTyr Pharma involved significant roles, including Associate Director and Program Scientific Lead, focusing on advancing biotechnology therapeutics and engaging with regulatory agencies. Minh-Ha holds a Ph.D. in Biomedical Sciences from UC San Diego and a Bachelor's Degree in Molecular, Cellular and Developmental Biology from UCLA.